Plasma EBF1 as a Novel Biomarker for Postmenopausal Osteoporosis.

He, Shi; Kang, Kai; Jing, Yuanhai; Wang, Qiang

He, Shi; Kang, Kai; Jing, Yuanhai; Wang, Qiang.

Afiliación

He S; The Second Ward of Department of Orthopedics, Daqing Longnan Hospital, Daqing, Heilongjiang, China.
Kang K; The Second Ward of Department of Orthopedics, Daqing Longnan Hospital, Daqing, Heilongjiang, China.
Jing Y; The Second Ward of Department of Orthopedics, Daqing Longnan Hospital, Daqing, Heilongjiang, China.
Wang Q; The Second Ward of Department of Orthopedics, Daqing Longnan Hospital, Daqing, Heilongjiang, China. Electronic address: lnwq_5852096@163.com.

J Clin Densitom ; 25(2): 230-236, 2022.

Article en En | MEDLINE | ID: mdl-34272166

Asunto(s)

Osteoporosis Posmenopáusica; Osteoporosis; Transactivadores; Absorciometría de Fotón; Biomarcadores/sangre; Densidad Ósea/fisiología; Colágeno Tipo I/genética; Femenino; Humanos; Vértebras Lumbares; Osteoporosis/tratamiento farmacológico; Osteoporosis Posmenopáusica/diagnóstico por imagen; Procolágeno; Transactivadores/sangre

Palabras clave

EBF1; GSTP1; PAX5; postmenopausal osteoporosis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Osteoporosis / Osteoporosis Posmenopáusica / Transactivadores Tipo de estudio: Screening_studies Límite: Female / Humans Idioma: En Revista: J Clin Densitom Asunto de la revista: ORTOPEDIA Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google